1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Li Y, Liang L, Dai W, Cai G, Xu Y, Li X,
Li Q and Cai S: Prognostic impact of programed cell death-1 (PD-1)
and PD-ligand 1 (PD-L1) expression in cancer cells and tumor
infiltrating lymphocytes in colorectal cancer. Mol Cancer.
15:552016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
ENCODE Project Consortium, . An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Schmitz SU, Grote P and Herrmann BG:
Mechanisms of long noncoding RNA function in development and
disease. Cell Mol Life Sci. 73:2491–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang S, Ma H, Zhang D, Xie S, Wang W, Li
Q, Lin Z and Wang Y: LncRNA KCNQ1OT1 regulates proliferation and
cisplatin resistance in tongue cancer via miR-211-5p mediated
Ezrin/Fak/Src signaling. Cell Death Dis. 9:7422018. View Article : Google Scholar : PubMed/NCBI
|
9
|
Li C, Miao R, Zhang J, Qu K and Liu C:
Long non-coding RNA KCNQ1OT1 mediates the growth of hepatocellular
carcinoma by functioning as a competing endogenous RNA of miR-504.
Int J Oncol. 56:857–858. 2020.PubMed/NCBI
|
10
|
Feng W, Wang C, Liang C, Yang H, Chen D,
Yu X, Zhao W, Geng D, Li S, Chen Z and Sun M: The dysregulated
expression of KCNQ1OT1 and Its interaction with downstream factors
miR-145/CCNE2 in breast cancer cells. Cell Physiol Biochem.
49:432–446. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
NCCN Clinical Practice Guidelines in
Oncology (NCCN Guidelines®)-Colon Cancer v1.2019. March
15–2019
|
12
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang Y, Kuang H, Xue J, Liao L, Yin F and
Zhou X: LncRNA AB073614 regulates proliferation and metastasis of
colorectal cancer cells via the PI3K/AKT signaling pathway. Biomed
Pharmacother. 93:1230–1237. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Dong Z, Yang P, Qiu X, Liang S, Guan B,
Yang H, Li F, Sun L, Liu H, Zou G and Zhao K: KCNQ1OT1 facilitates
progression of non-small-cell lung carcinoma via modulating
miRNA-27b-3p/HSP90AA1 axis. J Cell Physiol. 234:11304–11314. 2019.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Huang JL, Cao SW, Ou QS, Yang B, Zheng SH,
Tang J, Chen J, Hu YW, Zheng L and Wang Q: The long non-coding RNA
PTTG3P promotes cell growth and metastasis via up-regulating PTTG1
and activating PI3K/AKT signaling in hepatocellular carcinoma. Mol
Cancer. 17:932018. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lien EC, Dibble CC and Toker A: PI3K
signaling in cancer: Beyond AKT. Curr Opin Cell Biol. 45:62–71.
2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chen DL, Chen LZ, Lu YX, Zhang DS, Zeng
ZL, Pan ZZ, Huang P, Wang FH, Li YH, Ju HQ and Xu RH: Long
noncoding RNA XIST expedites metastasis and modulates
epithelial-mesenchymal transition in colorectal cancer. Cell Death
Dis. 8:e30112017. View Article : Google Scholar : PubMed/NCBI
|
21
|
Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu
XY, Yu ZW, Jia YH, Bai XF, Li L, et al: The lncRNA CRNDE promotes
colorectal cancer cell proliferation and chemoresistance via
miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol
Cancer. 16:92017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Sunamura N, Ohira T, Kataoka M, Inaoka D,
Tanabe H, Nakayama Y, Oshimura M and Kugoh H: Regulation of
functional KCNQ1OT1 lncRNA by β-catenin. Sci Rep. 6:206902016.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Sun H, Li Y, Kong H, Dai S and Qian H:
Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression
via miR-140-5p/SOX4 axis. Arch Biochem Biophys. 658:7–15. 2018.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Gong W, Zheng J, Liu X, Liu Y, Guo J, Gao
Y, Tao W, Chen J, Li Z, Ma J and Xue Y: Knockdown of long
non-coding RNA KCNQ1OT1 restrained glioma cells' malignancy by
activating miR-370/CCNE2 axis. Front Cell Neurosci. 11:842017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Huang M, Wang H, Hu X and Cao X: lncRNA
MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically
promote inflammation-related hepatocellular carcinoma progression.
Oncoimmunology. 8:e15186282018. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wang Z and Qin B: Prognostic and
clinicopathological significance of long noncoding RNA CTD-2510F5.4
in gastric cancer. Gastric Cancer. 22:692–704. 2019. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wen J, Wang H, Dong T, Gan P, Fang H, Wu
S, Li J, Zhang Y, Du R and Zhu Q: STAT3-induced upregulation of
lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid
carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT
signalling pathway. Cell Prolif. 52:e125692019. View Article : Google Scholar : PubMed/NCBI
|
28
|
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B
and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to
increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in
colorectal cancer progression. J Hematol Oncol. 11:892018.
View Article : Google Scholar : PubMed/NCBI
|